These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 15620435

  • 1. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
    Ota T, Takamura T, Nagai Y, Bando Y, Usuda R.
    Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
    [Abstract] [Full Text] [Related]

  • 2. Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes.
    Urakami T, Yoshida A, Suzuki J, Saito H, Wada M, Takahashi S, Mugishima H.
    Diabetes Res Clin Pract; 2009 Jan; 83(1):89-93. PubMed ID: 19019475
    [Abstract] [Full Text] [Related]

  • 3. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
    Kawasaki E, Kuriya G, Satoh T, Fujishima K, Moriuchi A, Fukushima K, Ozaki M, Abiru N, Yamasaki H, Eguchi K.
    Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, Todd I.
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [Abstract] [Full Text] [Related]

  • 5. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA.
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [Abstract] [Full Text] [Related]

  • 6. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T.
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K, Lernmark A, Becker C, Foltyn-Zadura A, Larsson K, Ivarsson SA, Törn C.
    Clin Lab; 2008 Mar; 54(7-8):227-35. PubMed ID: 18942490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes.
    Fakhfakh R, Haddouk S, Hadj Hamida YB, Kamoun T, Ayed MB, Hachicha M, Masmoudi H.
    Pathol Biol (Paris); 2008 May; 56(3):130-2. PubMed ID: 18178035
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E, Hallengren B, Agardh CD.
    Diabetes Metab Res Rev; 2004 May; 20(2):158-64. PubMed ID: 15037992
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of diabetes-associated autoantibodies in schoolchildren: the Karlsburg Type 1 Diabetes Risk Study.
    Schlosser M, Strebelow M, Rjasanowski I, Kerner W, Wassmuth R, Ziegler M.
    Ann N Y Acad Sci; 2004 Dec; 1037():114-7. PubMed ID: 15699502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Diagnostic value of protein tyrosine phosphatase-2beta antibody (IA-2betaA) in type 1 diabetes].
    Li H, Huang G, Zhang S, Wang X, Jin HL, Zhou ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):939-42. PubMed ID: 18756962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.